Emmvee Photovol. Q1 FY27 Earnings Call — Analysis (NSE: EMMVEE)

Emmvee posts record Q1FY27 on 51% revenue growth and 102% PAT jump, guided INR 2,400 Cr FY27 EBITDA, and confirmed its 6 GW integrated expansion is on track for Dec-26/Mar-27 commissioning.

22 Jul 2026 · Analysis by Alpha Inflection

The take

Q1FY27 Revenue from Operations ₹1,555 Cr ( +51% YoY ) . New guidance — FY27 fy27 ebitda ₹2,400 Cr . New story: Integrated capacity expansion execution .

Results

Revenue stood at INR 1,555 Cr (+51% YoY), EBITDA at INR 548 Cr (35% margin), and PAT at INR 380 Cr (+103% YoY), driven by record module (970 MW) and cell (454 MW) production and higher DCR mix.

Financial highlights

Guidance

Management targets approximately INR 2,400 Cr EBITDA for FY27, with the 6 GW integrated facility's module line commissioning by Dec-26 and cell line by Mar-27.

What management committed to

• FY27 EBITDA target of approximately INR 2,400 Cr. — INR 2,400 Cr, FY27
• [The 6 GW integrated TOPCon expansion] module line is expected to be commissioned by December 2026. — Q3FY27
• [The 6 GW integrated TOPCon expansion] cell line is expected to be commissioned by March 2027. — Q4FY27
• [The 6 GW expansion] total project cost is estimated at approximately INR 5,500 Cr, including hard costs of around INR 4,600 Cr. — INR 5,500 Cr, FY28
• Debt funding of approximately INR 3,300 Cr has been tied up at a cost of less than 8% for [the 6 GW integrated expansion]. — INR 3,300 Cr, FY28
• Orders representing approximately 60% of the total hard costs for [the 6 GW expansion] have already been placed. — 60% of ~INR 4,600 Cr, Q3FY27
• [Backward integration into ingot and wafer] facility will have a total of 9 GW and is planned in two phases, with 5 GW targeted in FY2029 and the remaining 4 GW in FY2030. — 5 GW in FY29, 4 GW in FY30, FY29
• Capital expenditure for [the ingot/wafer backward integration] is expected to be funded largely through internal accruals. — largely through internal accruals, FY29
• Non-DCR module EBITDA spread is expected in the range of INR 2.0–2.5/watt. — INR 2-2.5 /watt, FY27
• Cell EBITDA spread is expected in the range of INR 6.0–6.5/watt. — INR 6.0-6.5 /watt, FY27
• DCR module EBITDA spread is expected in the range of INR 8.5–9.0/watt. — INR 8.5-9 /watt, FY27

Key themes

ALMM-driven DCR shift and integrated capacity expansion

How the narrative shifted

• ALMM List 2 DCR demand shift: Management positions the June 2026 ALMM List 2 implementation as a structural demand driver that expands the addressable DCR market, favoring compliant, integrated manufacturers like Emmvee.
• Integrated capacity expansion execution: The 6 GW greenfield integrated cell-module facility is the primary near-term catalyst; management emphasizes on-schedule progress, fixed-price equipment ordering, and tied-up low-cost debt as evidence of execution capability.
• Backward integration into ingot/wafer: Framed as a margin-protection and supply-chain resilience move; timelines are medium-term (FY29-30), conditional on ALMM List 3 policy, and to be funded via internal accruals—signaling a capital-light, policy-contingent approach.
• Domestic cell supply tightness: Management notes that domestic TOPCon cell supply remains relatively tight post-ALMM List-2, a condition that supports pricing and margins for established cell manufacturers like Emmvee with operational DCR capacity.
• Rising cell utilization and mix benefits: Improving cell capacity utilization (83%) is highlighted as a key operational milestone that increases internal cell consumption, improves cost structure, and strengthens margin resilience.
• Geopolitical raw-material risk management: Management acknowledges building strategic raw-material inventory as a buffer against geopolitical disruptions and navigating new silver import procedures with proactive DGFT applications.

Operational commentary

• Module production hit a record 970 MW, up 53% YoY; cell production at a record 454 MW, up 26% YoY.
• Cell capacity utilization improved to 83%, driving higher in-house cell content in modules and better margin control.
• 6 GW integrated TOPCap cell-module expansion on track: module line commissioning by Dec-26, cell line by Mar-27; total project cost ~INR 5,500 Cr, debt of INR 3,300 Cr tied at <8%.
• ALMM List 2 implementation from June 2026 expands addressable DCR market beyond government schemes; management expects DCR demand to strengthen progressively through FY27.
• Medium-term backward integration into ingot/wafer (9 GW) planned in two phases (5 GW FY29, 4 GW FY30), subject to ALMM List 3 clarity, primarily to protect margins and reduce upstream volatility.
• DCR mix exceeded 50% of Q1FY27 revenue, including both DCR modules and merchant cell sales; merchant cell sales reached their highest-ever absolute level.
• Transition to G12R cell technology commenced; will lift effective nameplate capacity without changing headline utilization rate.

Analyst Q&A

• Q. Gross margin spread and movement from Q4 to Q1

  Management declined to provide gross margin spread, sticking to EBITDA per watt guidance; noted no material movement from Q4 to Q1.

• Q. Breakdown of margins for standalone cell sale vs DCR module vs non-DCR module

  Suhas Donthi provided specific EBITDA per watt figures: non-DCR module ~INR 2-2.5/watt, cell INR 6-6.5/watt, DCR module INR 8.5-9/watt.

• Q. When will order booking start for the 6 GW expansion and what quantum jump to expect?

  Management stated order inflow is already growing in tandem with expansion and pointed to 7+ GW of orders to be executed in the next 18 months, without providing a specific booking-start trigger or quantum jump target.

View source

Research and educational content only. Not investment advice.